跳至主要内容
临床试验/NCT01548222
NCT01548222已完成不适用

CGM Evaluation of Glucose Excursions in Basal Insulin Treated T2DM at Fasting Glucose Target

Diabetes Care Center1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2012年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
Percentage of time CGM glucose is <70mg/dl

研究概览

简要总结

This is a trial to determine if patients who are well controlled and on basal insulin are treated with excessive basal dose.

详细描述

In many clinical trials, basal insulin is titrated to only a fasting glucose goal. The usual final dose is >0.4U/kg. In carefully CGM monitored/titrated studies in both basal insulin alone or in pump-treated T2DM, we have found the basal insulin dose to be <0.3U/kg. This suggests that if guided by a single daily fasting glucose, titration may result in an excessive basal dose. This study will examine that issue.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Type 2 diabetes
  • Age 18 years and above
  • Concurrently on +/-thiazolidnedione +/-DDP IV inhibitors +/-metformin +/- glinides and basal insulin analogs
  • A1C 10% or below
  • Capable of self monitoring glucose at least 4 x a day
  • Previously compliant with clinical recommendations
  • Fasting blood glucose <110mg/dl average for 3 consecutive days
  • BMI <45 kg/m

排除标准

  • Urinary ketosis
  • Current or expected alternation in insulin sensitivity such as major surgery, infection, renal failure, glucocorticoid treatment, recent serious hypoglycaemic episode
  • Currently participating in another clinical trial
  • Using rapid insulin insulin
  • Pregnancy or nursing or the intention of becoming pregnant or not using adequate birth control
  • Significant liver or heart failure.

结局指标

主要结局

Percentage of time CGM glucose is <70mg/dl

时间窗: the subject will be followed for 9 days

The percentage of time CGM glucose is \<70 mg/dl during the basal glucose evaluation

次要结局

  • Percentage of time CGM glucose is <40 mg/dl(the subject will be followed for 9 days)
  • Determined hypoglycaemic episodes(the subject will be followed for 9 days)
  • Weight gain(the subject will be followed for 9 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验